Delirium due to Anticholinergic Drug Burden in Older Persons-Advances in Geriatric Medicine and Research-CSCIED科技核心评价数据库-手机版

Delirium due to Anticholinergic Drug Burden in Older Persons

Delirium due to Anticholinergic Drug Burden in Older Persons

ES评分 0 浏览量：902 下载量：0

DOI	10.20900/agmr20210004
刊名	Advances in Geriatric Medicine and Research AGMR
年，卷(期)	2021, 3(1)
作者	Anna Soldati*,Matteo Cesari,
作者单位	Geriatric Fellowship Program, University of Milan, Milan 20122, Italy ; Department of Clinical Sciences and Community Health, University of Milan, Milan 20122, Italy ;
Abstract	The cumulative effect of medications with anticholinergic activity (known as Anticholinergic Drug Burden, ADB) is associated with incident delirium and onset of adverse outcomes in older persons (e.g., cognitive and functional impairment). In a recent study by Egberts and colleagues, the association between delirium and ADB was demonstrated, mainly when assessed using the Anticholinergic Risk Scale (ARS). Although drugs with anticholinergic properties are often included in lists of potentially inappropriate medications, their prescription is still widespread. More efforts should be made to support deprescribing strategies and limit the prescription of potentially harmful medications.
KeyWord	anticholinergic drug burden; delirium; geriatrics; polypharmacy; deprescribing
基金项目
页码	-

参考文献
相关文献

1.Saxena S, Lawley D. Delirium in the elderly: a clinical review. Postgrad Med J. 2009;85(1006):405-13. doi: 10.1136/pgmj.2008.072025

2.Hshieh TT, Fong TG, Marcantonio ER, Inouye SK. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci. 2008;63(7):764-72. doi: 10.1093/gerona/63.7.764

3.Marcantonio ER. Delirium in Hospitalized Older Adults. N Engl J Med. 2017;377(15):1456-66. doi: 10.1056/NEJMcp1605501

4.American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616-31. doi: 10.1111/j.1532-5415.2012.03923.x

5.Laurila J, Laakkonen M-L, Tilvis RS, Pitkala KH. Predisposing and precipitating factors for delirium in a frail geriatric population. J Psychosom Res. 2008;65(3):249-54. doi: 10.1016/j.jpsychores.2008.05.026

6.Campbell N, Boustani M, Limbil T, Ott C, Fox C, Maidment I, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging. 2009;4:225-33. doi: 10.2147/cia.s5358

7.Collamati A, Martone AM, Poscia A, Brandi V, Celi M, Marzetti E, et al. Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence. Aging Clin Exp Res. 2016;28(1):25-35. doi: 10.1007/s40520-015-0359-7

8.Salahudeen MS, Hilmer SN, Nishtala PS. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. J Am Geriatr Soc. 2015;63(1):85-90. doi: 10.1111/jgs.13206

9.Egberts A, Moreno-Gonzalez R, Alan H, Ziere G, Mattace-Raso FUS. Anticholinergic Drug Burden and Delirium: A Systematic Review. J Am Med Dir Assoc. 2020:S1525-8610(20)30349-2. doi: 10.1016/j.jamda.2020.04.019

10.Ruxton K, Woodman RJ, Mangoni AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis. Br J Clin Pharmacol. 2015;80(2):209-20. doi: 10.1111/bcp.12617

11.Fox C, Smith T, Maidment I, Chan WY, Bua N, Myint PK, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing. 2014;43(5):604-15. doi: 10.1093/ageing/afu096

12.Cardwell K, Hughes CM, Ryan C. The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the “Oldest Old”: A Systematic Review of the Literature. Drugs Aging. 2015;32(10):835-48. doi: 10.1007/s40266-015-0310-9

13.Carnahan RM, Lund BC, Perry PJ, Pollock BG. A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice. Psychopharmacol Bull. 2002;36(2):24-39.

14.van Munster BC, Thomas C, Kreisel SH, Brouwer JP, Nanninga S, Kopitz J, et al. Longitudinal assessment of serum anticholinergic activity in delirium of the elderly. J Psychiatr Res. 2012;46(10):1339-45. doi: 10.1016/j.jpsychires.2012.06.015

15.Martocchia A, Spuntarelli V, Aiello F, Meccariello AL, Proietta M, Del Porto F, et al. Using INTERCheck® to Evaluate the Incidence of Adverse Events and Drug-Drug Interactions in Out- and Inpatients Exposed to Polypharmacy. Drugs Real World Outcomes. 2020;7(3):243-9. doi: 10.1007/s40801-020-00193-9

16.Cesari M, Marzetti E, Thiem U, Pérez-Zepeda MU, Van Kan GA, Landi F, et al. The geriatric management of frailty as paradigm of “The end of the disease era”. Eur J Intern Med. 2016;31:11-14. doi: 10.1016/j.ejim.2016.03.005

引用本文

Anna Soldati*,Matteo Cesari. Delirium due to Anticholinergic Drug Burden in Older Persons, Advances in Geriatric Medicine and Research. 2021; 3; (1). https://doi.org/10.20900/agmr20210004.

文献评论

相关学者

相关机构